59 related articles for article (PubMed ID: 12199354)
1. Reply of the Authors: Testosterone and luteinizing hormone predict semen parameter improvement in infertile men treated with anastrozole.
Naelitz BD; Lundy SD; Nowacki AS
Fertil Steril; 2024 Jul; 122(1):190. PubMed ID: 38616033
[No Abstract] [Full Text] [Related]
2. Commentary on "Testosterone and luteinizing hormone predict semen parameter improvement in infertile men treated with anastrozole".
Li D; Zeng X
Fertil Steril; 2024 Jul; 122(1):189. PubMed ID: 38494104
[No Abstract] [Full Text] [Related]
3. Assessment of the Aromatase Inhibitory Activity of Ma-Huang-Tang (MHT) and Its Active Compounds.
Jung DH; Hwang JT; Pyun BJ; Yu SY; Ko BS
Evid Based Complement Alternat Med; 2019; 2019():4809846. PubMed ID: 31929813
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel aromatase inhibitors using a homogeneous time-resolved fluorescence assay.
Ji JZ; Lao KJ; Hu J; Pang T; Jiang ZZ; Yuan HL; Miao JS; Chen X; Ning SS; Xiang H; Guo YM; Yan M; Zhang LY
Acta Pharmacol Sin; 2014 Aug; 35(8):1082-92. PubMed ID: 25047514
[TBL] [Abstract][Full Text] [Related]
5. Contemporary issues in precocious puberty.
Bajpai A; Menon PS
Indian J Endocrinol Metab; 2011 Sep; 15 Suppl 3(Suppl3):S172-9. PubMed ID: 22029021
[TBL] [Abstract][Full Text] [Related]
6. Treatment of autonomous ovarian follicular cyst with long-term anastrozole therapy.
Engiz O; Berberoglu M; Siklar Z; Bilir P; Ocal G
Indian J Pediatr; 2009 Sep; 76(9):950-1. PubMed ID: 19904510
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen improved final height prediction in a girl with McCune-Albright syndrome: patient report and literature review.
Sawathiparnich P; Osuwanaratana P; Santiprabhob J; Likitmaskul S
J Pediatr Endocrinol Metab; 2006 Jan; 19(1):81-6. PubMed ID: 16509532
[TBL] [Abstract][Full Text] [Related]
8. Use of aromatase inhibitors in precocious puberty.
Feuillan P; Merke D; Leschek EW; Cutler GB
Endocr Relat Cancer; 1999 Jun; 6(2):303-6. PubMed ID: 10731123
[TBL] [Abstract][Full Text] [Related]
9. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
Feuillan PP; Foster CM; Pescovitz OH; Hench KD; Shawker T; Dwyer A; Malley JD; Barnes K; Loriaux DL; Cutler GB
N Engl J Med; 1986 Oct; 315(18):1115-9. PubMed ID: 3093862
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review.
Bercaw-Pratt JL; Moorjani TP; Santos XM; Karaviti L; Dietrich JE
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):e9-e13. PubMed ID: 22051789
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial.
Eugster EA; Rubin SD; Reiter EO; Plourde P; Jou HC; Pescovitz OH;
J Pediatr; 2003 Jul; 143(1):60-6. PubMed ID: 12915825
[TBL] [Abstract][Full Text] [Related]
12. Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome.
Alves C; Silva SF
J Pediatr Endocrinol Metab; 2012; 25(3-4):323-5. PubMed ID: 22774233
[TBL] [Abstract][Full Text] [Related]
13. The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome.
Mieszczak J; Lowe ES; Plourde P; Eugster EA
J Clin Endocrinol Metab; 2008 Jul; 93(7):2751-4. PubMed ID: 18397987
[TBL] [Abstract][Full Text] [Related]
14. Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome.
Roth C; Freiberg C; Zappel H; Albers N
J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():945-8. PubMed ID: 12199354
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
